Analysts’ Ratings Reiterations for November 9th (AGEN, AJB, AROW, ASST, BE, BEN, BIOA, BOOT, CMPS, COCH)

Analysts’ ratings reiterations for Monday, November 9th:

Agenus (NASDAQ:AGEN) had its buy rating reaffirmed by analysts at B. Riley Financial. B. Riley Financial currently has a $16.00 price target on the stock, up from their previous price target of $14.00.

AJ Bell (LON:AJB) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 700 price target on the stock.

Arrow Financial (NASDAQ:AROW) had its overweight rating reiterated by analysts at Piper Sandler. The firm currently has a $45.00 target price on the stock, down from their previous target price of $46.00.

Strive (NASDAQ:ASST) had its buy rating reiterated by analysts at B. Riley Financial. They currently have a $27.00 target price on the stock, down from their previous target price of $33.00.

Bloom Energy (NYSE:BE) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a $335.00 price target on the stock.

Franklin Resources (NYSE:BEN) had its market perform rating reiterated by analysts at Keefe, Bruyette & Woods. They currently have a $38.00 target price on the stock, up from their previous target price of $37.00.

BioAge Labs (NASDAQ:BIOA) had its buy rating reissued by analysts at BTIG Research.

Boot Barn (NYSE:BOOT) had its buy rating reiterated by analysts at BTIG Research. They currently have a $195.00 target price on the stock.

Compass Pathways (NASDAQ:CMPS) had its buy rating reiterated by analysts at HC Wainwright.

Envoy Medical (NASDAQ:COCH) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $18.00 price target on the stock.

First BanCorp. (NYSE:FBP) had its neutral rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $28.00 price target on the stock, down from their previous price target of $30.00.

Fluor (NYSE:FLR) had its buy rating reissued by analysts at Truist Financial. Truist Financial currently has a $62.00 target price on the stock, down from their previous target price of $71.00.

Fervo Energy (NASDAQ:FRVO) had its outperform rating reaffirmed by analysts at Sanford C. Bernstein. They currently have a $47.00 price target on the stock.

H-power (LON:HPOW) had its speculative buy rating reissued by analysts at Canaccord Genuity Group. Canaccord Genuity Group currently has a GBX 25 target price on the stock.

International Consolidated Airlines Group (LON:IAG) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 645 price target on the stock.

Strategy (NASDAQ:MSTR) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $208.00 target price on the stock.

Nkarta (NASDAQ:NKTX) had its buy rating reaffirmed by analysts at Needham & Company LLC.

NVIDIA (NASDAQ:NVDA) had its buy rating reiterated by analysts at The Goldman Sachs Group. They currently have a $300.00 price target on the stock.

NVIDIA (NASDAQ:NVDA) had its outperform rating reiterated by analysts at Royal Bank Of Canada. They currently have a $330.00 target price on the stock.

Oklo (NYSE:OKLO) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $90.00 target price on the stock.

Oklo (NYSE:OKLO) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $36.00 target price on the stock.

Insulet (NASDAQ:PODD) had its hold rating reissued by analysts at Truist Financial. The firm currently has a $160.00 price target on the stock, up from their previous price target of $153.00.

Praxis Precision Medicines (NASDAQ:PRAX) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $826.00 price target on the stock.

QinetiQ Group (LON:QQ) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 600 price target on the stock.

Remitly Global (NASDAQ:RELY) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $30.00 price target on the stock.

Rivian Automotive (NASDAQ:RIVN) had its buy rating reaffirmed by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $22.00 target price on the stock.

StandardAero (NYSE:SARO) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $35.00 price target on the stock.

Sylvamo (NYSE:SLVM) had its buy rating reiterated by analysts at Truist Financial. Truist Financial currently has a $47.00 price target on the stock, up from their previous price target of $40.00.

Sui Group (NASDAQ:SUIG) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $3.40 target price on the stock.

Bancorp (NASDAQ:TBBK) had its overweight rating reaffirmed by analysts at Piper Sandler. They currently have a $62.00 target price on the stock, down from their previous target price of $75.00.

Tharisa (LON:THS) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 230 target price on the stock.

Univest Corporation of Pennsylvania (NASDAQ:UVSP) had its neutral rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $45.00 target price on the stock, down from their previous target price of $46.00.

Vir Biotechnology (NASDAQ:VIR) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $22.00 price target on the stock.

Western Union (NYSE:WU) had its underweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $6.00 price target on the stock.

WAVE Life Sciences (NASDAQ:WVE) had its buy rating reiterated by analysts at B. Riley Financial. They currently have a $18.00 price target on the stock.

Zegona Communications (LON:ZEG) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 2,300 price target on the stock.